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Abstract
TheWnt system is highly complex and is comprised of canonical and non-canonical path-
ways leading to the activation of gene expression. Our aim was to examine changes in the
expression of Wnt ligands and regulators during hepatic stellate cell (HSC) transdifferentia-
tion and assess the relative contributions of the canonical and non-canonical Wnt pathways
in fibrogenic activated HSC. The expression profile of Wnt ligands and regulators in HSC
was not supportive for a major role for β-catenin-dependent canonical Wnt signalling, this
verified by inability to induce Topflash reporter activity in HSC even when expressing a con-
stitutive active β-catenin. We detected expression of Wnt5a in activated HSC which can sig-
nal via non-canonical mechanisms and showed evidence for non-canonical signalling in
these cells involving phosphorylation of Dvl2 and pJNK. Stimulation of HSC or Kupffer cells
with Wnt5a regulated HSC apoptosis and expression of TGF-β1 and MCP1 respectively.
We were unable to confirm a role for β-catenin-dependent canonical Wnt in HSC and
instead propose autocrine and paracrine functions for Wnts expressed by activated HSC
via non-canonical pathways. The data warrant detailed investigation of Wnt5a in liver
fibrosis.
Introduction
Hepatic stellate cells (HSC) are widely recognised as the major cellular origin of activated pro-
fibrogenic myofibroblasts in chronic liver disease, irrespective of disease aetiology. In response
to liver damage HSC undergo an epigenetically-regulated transdifferentiation to adopt a myofi-
broblast-like phenotype characterised by proliferation, contractile ability and the secretion of
vast amounts of fibril-forming extracellular matrix (ECM) proteins[1]. The persistence of these
so-called activated HSC (aHSC) leads to the net deposition of ECM and the progressive remod-
elling of liver tissue towards a fibrotic state. Hence, aHSC are major cellular drivers of fibrogen-
esis and are rational targets for the design of anti-fibrotics aimed at preventing the progression
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of chronic liver disease to cirrhosis. Key to exploiting the aHSC for the development of anti-
fibrotic strategies is a deep understanding of the regulatory cell signalling processes that dictate
their fibrogenic activities.
Growing evidence suggests that tissue injury is accompanied by the reactivation of embry-
onic signalling pathways such as those controlled by the morphogen families Hedgehog (Hh),
Notch and Wnt[2]. During development, these morphogen families are key regulators of cell
fate specification, proliferation and migration indicating strong potential for a role in regulat-
ing wound repair and tissue regeneration[3,4]. Increased Hh, Notch and Wnt signalling has
been implicated in promoting HSC transdifferentiation and significant improvement in fibro-
sis is documented in experimental models when these pathways are inhibited[5]. However, the
regulation of these developmental morphogens is highly complex and knowledge of the mecha-
nisms by which they control the phenotype and function of HSC is incomplete.
The Wnt systems is comprised of signalling proteins that are highly evolutionary conserved
secreted glycoproteins with a critical role in developmental regulation[6]. In the adult, aberrant
Wnt signalling has been linked to numerous pathologies, notably cancer but also bone abnor-
malities and arthritis[7]. Emerging evidence also supports a role in promoting tissue fibrosis in
variety of organs and experimental models[8,9]. Once secreted, Wnts signal through interac-
tion with membrane bound Frizzled (Fzd) receptors, resulting in phosphorylation of the down-
stream mediator Dishevelled (Dvl). Phosphorylated Dvl propagates Wnt signalling by three
potential pathways: the canonical β-Catenin associated pathway, the non-canonical Planar Cell
Polarity (PCP) pathway or the non-canonical Calcium associated (Wnt/Ca2+) pathway. The
relative contributions of these distinct intracellular Wnt signalling pathways towards the regu-
lation of myofibroblast fate and function, as well as to the control of fibrogenesis per se,
remains poorly defined.
Recent work from a number of laboratories has suggested that Wnt signalling is activated in
HSCs upon liver injury and that the expression of many components of the different Wnt path-
ways are modulated during HSC transdifferentiation including Wnt ligands, Frizzled receptors,
the LRP5 co-receptor and the expression of nuclear β-catenin[10–13]. Moreover, the ability to
modulate the fibrogenic activities of HSC with the administration of inhibitors of Wnt signal-
ling is well documented. However, the role of canonical β-catenin-dependent Wnt signalling in
HSCs is unclear due to contradictory data in the recent literature that argues for both inhibitory
and activatory roles[11,13,14]. Furthermore, little attention has focussed on the potential for
non-canonical Wnt signalling playing a role in HSCs. Here, we confirm using primary rodent
and human cells that HSC activation is accompanied with dramatic changes in the expression
of Wnt ligands and their regulatory factors. By studying the downstream intracellular Wnt reg-
ulators we fail to provide evidence for β-catenin-dependent signalling, but instead discover a
role for non-canonical β-catenin-independent Wnt pathways in the control of the phenotype
of aHSC and their expression of fibrogenic genes.
Results
Characterisation of Wnt ligands, receptors and antagonists in cultured
primary HSC
We began by determining the expression of Wnt ligands at the transcript level in rat aHSC (Fig
1A). We observed expression of Wnt 4, 5a and 6 while Wnts 7b, 9b or 3a could not be detected.
Comparison between freshly isolated qHSC and 7-day cultured aHSC demonstrated activa-
tion-associated enhancement of Wnt4 and Wnt5a indicating that these ligands may be more
highly expressed in fibrogenic aHSC (Fig 1B). A more detailed time course of rat HSC activa-
tion revealed that Wnt4 and Wnt5a transcripts progressively accumulate as the cell adopts its
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Fig 1. Activated HSCs expressWnt4, Wnt5a andWnt6. (A) Products of RT-PCR for Wnt4, Wnt5a, Wnt6, Wnt7b, Wnt9b andWnt3a in day 7 rat aHSCs,
liver and brain (+ve) visualised on agarose gels using UV. Water only (-ve) serves as negative control. β-Actin serves as a loading control (B) qRT-PCR for
Wnt4 andWnt5a in culture activated rat HSCs (quiescent (qHSC) or day 7 activated HSC (aHSC) (n = 5). (C) qRT-PCR for Wnt4 andWnt5a in rat HSCs after
0,4,6,8 and 10 days in culture, (n = 3) (D) Western Blot demonstrates increasedWnt5a expression in rat HSCs activated after 7 days in culture. Wnt3a protein
expression is absent in both quiescent (qHSC) and activated (aHSC) cells. αSMA and TGFβ 1 serve as markers of HSC activation. Huh7 protein lysate
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activated phenotype with maximal expression observed between days 6 and 10 when the cells
have matured to a myofibroblastic state (Fig 1C) Western blotting for alpha smooth muscle
actin (α-SMA) and TGFβ confirmed that 7-day cultured rat HSC were in an activated state
while blotting for Wnt5a confirmed induction of this Wnt ligand at the protein level (Fig 1D).
By comparison we did not detect expression of Wnt3a protein in either qHSC or aHSC. We
were also able to identify expression of Wnt5a in the aHSC conditioned media indicative of
active secretion of Wnt5a protein (Fig 1E). To corroborate these data, Wnt4 andWnt5a
mRNA were induced in ex-vivo mouse HSC isolated from either CCL4- or BDL-injured livers
(Fig 1F). Finally, expression of Wnt5a, Wnt 3a and Wnt10b was determined in human HSCs.
In contrast to previous studies we failed to detect significant levels of canonical Wnt3a and
only low levels of Wnt10b whereas Wnt5a was readily detectable in human HSC. (Fig 1G)
Wnt ligands trigger cell signalling via interaction with members of Frizzled (Fzd) receptors
or a variety of non-canonical receptors including ROR1, ROR2, Ryk and Ptk7 [15]. Transcripts
for Fzd1, Fzd2, Fzd4, Fzd5, Fzd8, ROR1, ROR2, Ryk and Ptk7 were all detected in HSC by
semi-quantitative RT-PCR (Fig 2A). Comparison between qHSC and aHSC indicated that only
one Fzd gene, Fzd2, is upregulated with HSC activation, whereas transcripts for Fzd1, Fzd4,
Fzd8, ROR1 and ROR2 were all down-regulated in aHSC relative to qHSC. Quantitative
RT-PCR confirmed these activation-associated alterations in receptor expression with
serves as a positive control (E) Western Blot for Wnt5a protein in whole cell rat aHSC (Day 7) lysate and concentrated conditioned media (F) qRT-PCR for
Wnt4 andWnt5a in HSCs isolated frommouse livers injured by carbon tetrachloride injection (CCl4) or Bile Duct Ligation (BDL) (n = 3) (G) Products of
RT-PCR for Wnt3a, Wnt10b andWnt5a in 3 preparations of human HSCs visualised on agarose gels using UV. Wnt overexpressing LX-2 cells were used as
a positive control (+ve). qRT-PCR results expressed as fold change normalised to control ± SEM. *p<0.05 (Student’s T-test).
doi:10.1371/journal.pone.0142794.g001
Fig 2. Wnt receptor expression alters upon HSC transdifferention. (A) Products of RT-PCR for Fzd Receptors and non canonical receptors in rat qHSCs
and aHSCs visualised on agarose gels using UV. (B) qRT-PCR for Fzd receptors in rat qHSC and aHSC. (n = 5) (C) qRT-PCR for non-canonical receptors in
rat qHSC and aHSC (n = 3), results expressed as fold change normalised to control ± SEM. *p<0.05, ***p<0.001 (Student’s T-test).
doi:10.1371/journal.pone.0142794.g002
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enhancement of Fzd2 and suppression of Fzd4, Fzd8 and ROR1 (Fig 2B and 2C). We also con-
firm expression of Fzd2 and Fzd8 at the protein level. (S1A Fig)
The interaction of Wnt ligands with their cell surface receptors is under tight extracellular
regulation by soluble proteins that compete for their binding; these include members of the
secreted frizzled-related proteins (sFRP1-5) and the dickkopf (Dkk1-4) family. HSC activa-
tion was accompanied by induction of sFRP1, sFRP4 and Dkk3 mRNAs which was detected
by both semi-quantitative (Fig 3A) and quantitative (S1B Fig) assays. By contrast only low
levels of sFRP2 (S1B Fig) and other Wnt antagonists (Dkk1, Dkk2, Dkk4, sFRP5 –not shown)
were found in HSC with no obvious differences in expression between quiescent and activated
Fig 3. Extracellular interactors of Wnt are upregulated upon HSC transdifferentiation. (A) Products of RT-PCR for sFRP1, sFRP4 and Dkk3 in rat
qHSCs and aHSCs. visualised on agarose gels using UV. (B) Western blot for sFRP4 in culture activated rat HSCs. (C) qRT-PCR for Wnt target genes in LX-
2 cells treated with 5nM recombinant sFRP1 or sFRP5 (n = 4) (D) qRT-PCR for fibrogenic genes in LX-2 cells treated with 5nM recombinant sFRP1 or sFRP5
(n = 4) (E) qRT-PCR for adipogenic genes in LX-2 cells treated with 5nM recombinant sFRP1 or sFRP5 (n = 4). Results expressed as fold change normalised
to control ± SEM; (n = 4). *p<0.05, (Student’s T-test).
doi:10.1371/journal.pone.0142794.g003
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cells. Western blot confirmed induction of sFRP4 protein with HSC activation and mainte-
nance of its expression in fully activated myofibroblasts (Fig 3B). Of note, canonical Wnt sig-
nalling has been reported to be critical for adipogenic differentiation and to be strongly
suppressed by sFRP4 [16]. Hence, culture-induced sFRP4 (and SFRP1 and Dkk3) combined
with reduced surface expression of several Wnt receptors may be important for the switch
from the adipogenic phenotype of qHSC to the myofibroblastic phenotype of aHSC. Treat-
ment of LX2 cells with recombinant sFRP1 decreased expression of the fibrogenic gene
TGF1β, albeit not significantly. Treatment of LX2 cells with recombinant sFRP5 demon-
strated a greater effect, significantly reducing expression of Wnt targets (cMyc, CyclinD) (Fig
3C) and fibrogenic genes (Col1A1, αSMA, PDGFα)(Fig 3D). Additionally we found a repres-
sive effect on the expression of the adipogenesis-associated genes CEBPα and CD36, however
the impact of sFRP5 on the adipogenic phenotype was limited as we found no effect on
LRXα, PPARγ or adipsin (Fig 3E).
Activated HSC do not support canonical β-catenin-dependent Wnt
signalling
To determine the ability of aHSC to respond to canonical Wnt signalling, human LX-2 were
co-transfected with the canonical Wnt luciferase reporter Topflash and expression vectors for
Wnt3a and Wnt10b. To control these assays similar transfections were carried out in HEK293
cells which are known to support β-catenin-dependent Wnt signalling[17]. As anticipated co-
transfection of the canonical Wnts activated the Topflash reporter in HEK293 cells, however
no reporter activity was detected in LX-2 cells transfected with either Wnt3a or Wnt10b (Fig
4A). In addition, transfection of Wnt10b failed to induce expression of the Wnt target gene
Axin2 in LX-2 which by contrast was up-regulated 3-fold by Wnt10b transfection in HEK293
cells (Fig 4B). Over-expression of a constitutive active mutant β-catenin (S2 Fig) induced Top-
flash activity by 40-fold in HEK293 cells (Fig 4C) and enhanced the expression of endogenous
Axin2, cMyc and Cyclin D (Fig 4D). However, neither the reporter nor endogenous Axin2,
cMyc and Cyclin D were stimulated in LX-2 cells, this confirming that the human HSC cell
line does not support canonical Wnt signalling (Fig 4C and 4D). Expression of constitutive
active β-catenin induced Topflash in primary rat dermal fibroblasts but was inactive in pri-
mary rat aHSC (Fig 4E). These data were indicative of defective β-catenin-dependent Wnt sig-
nalling in HSC. To investigate this further, rat HSC protein extracts were probed by
immunoblot for expression of active (de-phosphorylated) and total β-catenin (Fig 4F) Freshly
isolated qHSC lacked expression of active β-catenin, whereas HSC cultured for 7 days
expressed abundant levels of active β-catenin such that pharmacological activation with a
GSK3β inhibitor (CT99021) made little difference to the amount of active protein detected.
Furthermore, active β-catenin was readily detected in the HSC nucleus, this ruling out a defect
in nuclear translocation (S3 Fig). Once in the nucleus, β-catenin interacts with a variety of dif-
ferent proteins that impact on its stability and its ability to stimulate target gene transcription
[18,19]. Scaffold proteins (Pyg1, Pyg2, BCL9, BCL92) that tether β-catenin to its transcription
factor partners the TCF/LEF proteins, were all expressed at the mRNA level in LX-2 and
HEK293 (Fig 4G) as was the nuclear repressor of β-catenin Chibby, which in primary rat HSC
was found to undergo a dramatic diminution in expression with culture-induced activation
(Fig 4H). The transcriptional activation of β-catenin-target genes is dependent on its interac-
tion with TCF/LEF transcription factors [20]. Comparison of the expression of TCF/LEF pro-
teins between HEK293 and LX-2 cells indicated a very low level of TCF1 and LEF1 in the HSC
line and decreased levels of TCF4, by contrast TCF3 was expressed to a similar level between
HEK293 and LX-2 (Fig 5A). These data were of particular interest since TCF1, TCF4 and
Non-Canonical Wnt Predominates in Activated Hepatic Stellate Cells
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Fig 4. βCatenin/TCF activity appears absent in HSCs and the LX-2 cell line. (A) TOPFLASH luciferase assay in Wnt3a and 10b overexpressing HEK293
and LX-2 cells, n = 2 (B) qRT-PCR for Axin2 in Wnt10b overexpressing LX-2 and HEK293 cells n = 3 (C) TOPFLASH assay in Ser37-βCatenin
overexpressing LX-2 and HEK293 cells, (n = 4) (D) qRT-PCR for Axin2, Cyclin D and cMyc in Ser37-βCatenin overexpressing LX-2 and HEK293 cells,
(n = 3) (E) TOPFLASH assay in Ser37-βCatenin overexpressing rat HSCs and dermal fibroblasts (DFs), (n = 2) (F) Western Blot for total and active form of
βcatenin in qHSC and aHSC treated with vehicle control or CT99021 for 24hours. Ser37-βcatenin overexpressing HEK293 cells were used as a positive
Non-Canonical Wnt Predominates in Activated Hepatic Stellate Cells
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LEF1 are generally considered to be activators of β-catenin-dependent transcription whereas
TCF3 may have a more repressive function[21,22]. However, over-expression of LEF1 did not
enable LX-2 to support transcriptional activity of co-transfected constitutive active β-catenin
(Fig 5B). This result indicates that aHSC may establish multiple regulatory checkpoints to
ensure blockade of canonical Wnt signalling. Indeed, exposure of HEK293 cells to LX-2-con-
ditioned media is able to partly inhibit constitutive active β-catenin signalling (Fig 5C), which
may be due to the secretion of inhibitory sFRPs by HSC, this idea being confirmed by demon-
strating the ability of overexpressed sFRP4 to inhibit Topflash reporter in HEK293 transfected
with constitutive active β-catenin (Fig 5D).
control. (G) Products of RT-PCR for Pyg1, Pyg2, BCL9, BCL92 and Chibby in HEK293 and LX-2 cells visualised on agarose gels using UV. (H)qRT-PCR for
Chibby in rat HSCs at 0,4,6,8 and 10 days in culture, (n = 3). Luciferase results represented as fold change of Firefly to Renilla luciferase ratio (F/R)
normalised to control ± SEM. qRT-PCR results expressed as fold change normalised to control ± SEM. *p<0.05, (Student’s T-test).
doi:10.1371/journal.pone.0142794.g004
Fig 5. Expression of TCF/LEF transcription factors appears reduced in LX-2 cells. (A) Western Blot for
TCF1, TCF3, TCF4 and LEF1in separate samples of LX-2 and HEK293 cells (B) TOPFLASH assay in
HEK293 cells after 24hours incubation with conditioned medium from either HEK293 or LX-2 cells, (n = 4).
(C) TOPFLASH assay in LX-2 cells overexpressing LEF1 and Ser37-βcatenin (n = 3) (D) TOPFLASH assay
in HEK293 cells overexpressing Ser37-βCatenin or Ser37-βCatenin and sFRP4, (n = 3). Luciferase results
represented as fold change of Firefly to Renilla *p<0.05 (Student’s t-test).
doi:10.1371/journal.pone.0142794.g005
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Non-canonical Wnt signalling in HSCs
Having failed to find evidence for β-catenin-dependent canonical Wnt activity in HSC we
turned our attention to non-canonical Wnt signalling which is mediated via JNK- and Cam-
Kii/NFAT-dependent pathways[23,24]. Exposure of primary rat HSC to Wnt ligands Wnt5a
andWnt10b led to a substantial induction of active phosphorylated JNK (p-JNK) and
enhanced expression of CamKii (Fig 6A). Dishevelled proteins (Dvl1-3) function as key mem-
brane-proximal intracellular mediators of canonical and non-canonical Wnt signalling [25].
Phosphorylation of Dvl2 has been functionally associated with activation of non-canonical
Wnt signal transduction and can be assessed by Dvl2 electrophoretic mobility shift[26].
Fig 6. HSCs upregulated non-canonical effectors uponWnt stimulus. (A) Western blot for total (T) and phosphorylated (P) forms of JNK and CamKii in
two preparations of rat aHSCs treated for 24 hours with either control (-), Wnt5a or Wnt10b conditioned media. (B) Western blot for Dvl2 in two preparations of
rat HSCs at 0,4,6,8 and 10 days in culture. (C) Western Blot for Dvl2 in LX-2 cells overexpressing Wnt3a, Wnt5a or Wnt10b. (D) Diagram illustrating points in
Wnt pathway for which inhibitors were chosen: Wnt secretion (IWP2) and Dvl-PDZ domain function (Dvl-PDZ). (E) Western Blot for Dvl2 in rat HSCs treated
with 1–20 μM of IWP2 (F) qRT-PCR for profibrotic markers in vehicle control (DMSO) and 20μM IWP2 treated rat aHSCs, (n = 4). (G)qRT-PCR for NFAT3,
Sox9 and Axin2 in vehicle control (DMSO) and 5μMPDZ-Inhibitor treated rat aHSCs, (n = 3) (H) qRT-PCR for profibrotic markers in vehicle control and 5μM
PDZ-Inhibitor treated rat aHSCs (n = 3). qRT-PCR results expressed as fold change normalised to control ± SEM *p<0.05 (Student’s t-test).
doi:10.1371/journal.pone.0142794.g006
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Immunoblotting for Dvl2 with protein extracts from primary rat HSC representing a time
course for culture-induced activation not only showed activation-dependent induction of Dvl2
expression (appearing at culture day 3) but also revealed a progressive electromobility shift as a
function of days in culture, with day 7 aHSC predominantly expressing the low mobility hyper-
phosphorylated modified Dvl2 (Fig 6B). Of note, treatment of protein extracts with alkaline
phosphatase selectively depleted this lower mobility form of Dvl2 confirming that the electro-
phoretic shift is due to phosphorylation (S4 Fig) Over-expression of Wnt3a, Wnt5a or Wnt10b
into LX-2 cells induced an Dvl2 electrophoretic mobility shift confirming the ability of HSC to
support Wnt signalling via Dvl2 activation (Fig 6C). Moreover, media collected fromWnt5a
transfected LX-2 (S5 Fig) was able to activate low-mobility forms of Dvl2 in primary rat HSC
(S6A Fig) and stimulated a modest increase in expression of α-SMA and transforming growth
factor beta (TGFβ1) transcripts (S6B Fig). To determine the functional relevance of Wnt signal
transduction in HSC the effects of Wnt inhibitors that have distinct molecular targets (as illus-
trated in Fig 6D) was examined in primary rat aHSC. IWP2 is an antagonist of Porcupine
(Porc), which is responsible for the palmitoylation and subsequent secretion of Wnt ligands
[27]. Dvl-PDZ targets the central PDZ domain of the Dvl proteins preventing their interaction
with Fzd receptors[28]. ICG001 is an inhibitor of β-catenin interaction with its transcriptional
co-activator CBP and as such is an inhibitor of canonical Wnt signalling[29]. Treatment of rat
aHSC with IWP2 dose-dependently suppressed p-Dvl2 (top band onWestern blot, Fig 6E) and
suppressed α-SMA and collagen IA1 mRNA expression (Fig 6F). Dvl-PDZ, which is expected
to suppress all downstreamWnt signalling, lowered expression of commonWnt target genes
Sox9 and Axin2 (Fig 6G) and (as seen with IWP2) also significantly inhibited expression of α-
SMA and collagen IA1 transcripts (Fig 6H). By contrast ICG001 was without effect on fibro-
genic gene expression (S7A Fig) but did appear to cause rounding up of cells and apoptosis as
determined by acridine orange staining (S7B and S7C Fig). We conclude from the effects of
IWP2 and Dvl-PDZ that non-canonical Wnt signalling contributes to regulation of fibrogenic
gene expression in aHSC.
Wnt5a protects HSC from apoptosis and stimulates fibrogenic
characteristics of Kupffer cells
Our observation that HSC secrete and respond to Wnt5a by activating Dvl2 and downstream
non-canonical Wnt signalling encouraged us to further examine the functional contribution of
this Wnt ligand to fibrogenesis. As before, primary rat aHSC were exposed to conditioned
media from cultures of Wnt5a over-expressing LX-2 cells prior to determining effects on mor-
phology (Fig 7A), proliferation by MTT assay (Fig 7B) and expression of PCNA and c-Myc (S8
Fig), apoptosis by acridine orange staining (Fig 7C and S9 Fig) and wound-induced migration
by scratch wound assay (Fig 7D). The only phenotypic characteristic that was responsive to
Wnt5a was HSC apoptosis where a modest protection to serum-starvation-induced cell death
was measured (Fig 7C). We were also able to show protective effects of Wnt5a in transfected
LX-2, whereas by contrast over-expression of Wnt10b appeared to stimulate apoptosis (Fig
7E). Finally, we were interested to determine if HSC-derived Wnt5a is able to exert paracrine
effects on Kupffer cells (KC). To this end, primary rat KC were exposed to either control LX-2
conditioned media or to media conditioned by LX-2 transfected with Wnt5a. Measurement of
transcripts for secreted inflammatory and fibrogenic mediators was performed and indicated
that paracrine Wnt5a can stimulate KC expression of pro-fibrogenic TGFβ1 and monocyte
chemoattractant protein 1 (MCP1) (Fig 7F). Western blot confirmed that Wnt5a induced
TGFβ1 at the protein level (Fig 7G). We conclude that Wnt5a can exert autocrine control over
Non-Canonical Wnt Predominates in Activated Hepatic Stellate Cells
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HSC survival and stimulate the expression of soluble profibrogenic mediators by KC, this sug-
gests that Wnt5a contributes to the persistence of fibrogenesis in the diseased liver.
Discussion
TheWnt signalling system has been the subject of considerable attention in HSCs and liver
fibrosis with recent reports suggesting functions in HSC transdifferentiation, proliferation,
apoptosis, control of fibrogenic gene expression and regulatory interactions of aHSC with
other liver cell types and physiological responses such as hepatocellular regeneration[11,13,14].
However, a clear understanding of which components of the highly complex Wnt system are
of functional importance in HSC is lacking, as is knowledge of signalling pathways through
which Wnt ligands mediate their fibrogenic effects. In particular, the literature is confusing
concerning the role played by canonical β-catenin-dependent Wnt signalling, with some
reports claiming active canonical Wnt regulating functions of aHSC, but others suggesting that
Fig 7. Wnt5a stimulus influences HSC survival and expression of profibrotic markers in Kuppfer cells. (A) Rat aHSCs were treated with control or
Wnt5a conditioned medium and visualised by bright field microscopy. (B) Proliferation was assessed by MTT assay (C) Acridine Orange staining was used to
quantify apoptotic response upon serum withdrawal (D) Migratory potential was assessed by scratch wound assay (E) Apoptotic response in LX-2 cells
overexpressing Wnt 5a orWnt10b was also assessed by acridine orange staining in standard culture conditions (10% FCS) or serum free conditions. Data
presented as number of apoptotic cells as percentage of total cell number. (F) qRT-PCR for profibrotic markers in control or Wnt5a conditioned medium
treated rat Kuppfer cells, (n = 3) (G) Western Blot for TGFB1 expression in control or Wnt5a conditioned medium treated Kuppfer cells. qRT-PCR results are
expressed as fold change normalised to control ± SEM *p<0.05, **p<0.01, ***p<0.001 (Student’s t-test).
doi:10.1371/journal.pone.0142794.g007
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canonical Wnt operates in qHSC and is suppressed in aHSC[11,13,14]. We therefore consid-
ered it timely to carry out a detailed analysis of the expression of Wnt ligands, receptors and
regulators in HSC and to ask with primary HSC which Wnt signalling pathways are active and
contributing physiologically to HSC function and fibrogenesis.
The main conclusion from our data is that at least in vitro there is little concrete evidence in
favour of a role for canonical β-catenin-dependent Wnt signalling in aHSC. Rather on the con-
trary, the aHSC is lacking a number of factors for this pathway to be active (Fig 8). These defi-
ciencies include low-level autocrine production of canonical Wnt ligands, a global down-
regulation of Fzd receptor genes, abundant expression of repressive sFRP proteins including
sFRP4, a well-established suppressor of β-catenin-dependent signalling[16], and low-level
expression of the transcriptional mediators TCF1, TCF4 and LEF1. Despite repeated attempts
in LX-2 and with numerous independent cultures of primary HSC we were unable to obtain
measurable levels of β-catenin-dependent Topflash activity. Surprisingly this was also the case
when co-transfecting with a constitutive active β-catenin that bypasses the need for upstream
signalling events. The precise deficiency in aHSC that prevents β-catenin-dependent Wnt sig-
nalling is not yet clear but may as we suggest be due to a combined low-level expression of
numerous key regulatory components. Alternatively, we have shown that as HSC transdiffer-
entiate they acquire abundant expression of hyper-phosphorylated Dvl2, which in this form
negatively regulates canonical Wnt[30]. Conceptually it is not unreasonable for canonical Wnt
signalling to be suppressed in aHSC given that Wnt-activated β-catenin is required for adipo-
genesis[31]. Highly active canonical Wnt signalling may be incompatible with HSC transdiffer-
ention and as previously reported by Kordes et al [13] is more expected to be a feature of the
Fig 8. Possible Points of Canonical Wnt Inhibition. This study has highlighted six possible points of
canonical Wnt inhibition occurring in HSCs. (1) Predominantly non-canonical ligand expression. Non
canonical signalling is inhibitory to canonical signalling (2) Decreased Fzd receptor expression, reducing
response to canonical ligands secreted by other cells (3) Increased sFRP expression (4) Increased
expression of other morphogens such as Notch, able to directly inhibit βCatenin. In the nucleus, HSCs
express higher levels of the repressive TCF3 in comparision to the other TCF/LEF family members
associated with transcriptional activation(5) (6) Transdifferentiation is associated with upregulation of SOX9,
direct inhibitor of βCatenin activity.
doi:10.1371/journal.pone.0142794.g008
Non-Canonical Wnt Predominates in Activated Hepatic Stellate Cells
PLOS ONE | DOI:10.1371/journal.pone.0142794 November 13, 2015 12 / 18
adipogeneic phenotype of the qHSC. Despite these observations we were able to confirm the
expression of β-catenin in aHSC and its localisation to the nucleus. A likely explanation for this
apparent paradox is that β-catenin might function as a signalling molecule outside of the con-
text of the canonical Wnt pathway and in this way be required for aHSC phenotype and/or
function. As an example, interactions between β-catenin and members of the TGF-β1 regulated
Smad proteins have been observed indicating coupling of Wnt and Smad components that
may expand the mechanisms by which these proteins regulate gene transcription[32,33]. In
order to properly define functions for β-catenin in HSC and their fibrogenic activities it will be
necessary to genetically manipulate the β-catenin gene in vivo and we await these future experi-
ments with much interest.
Our second conclusion was that aHSC abundantly express and secrete Wnt5a, which may
through non-canonical signalling pathways and via both autocrine and paracrine mecha-
nisms promote fibrogenesis. In previous work Wnt5a was reported as an induced transcript
with culture-activation of rat HSC[11,12] and by proteomic analysis of LX-2 to be a compo-
nent of the fibrotic ECM [14]. Here, we confirmWnt5a expression by aHSC and extend these
reports by demonstrating active secretion of the ligand by aHSC, autocrine suppression of
HSC apoptosis and paracrine stimulation of TGF-β1 and MCP-1 fibrogenic factors by KC.
Rashid et al were able to localise Wnt5a to fibrotic and peri-fibrotic regions of diseased
human and rodent liver tissue suggesting that aHSC may be a predominant source of this
Wnt ligand in the diseased liver (15). Studies in lung fibroblasts have implicated a role for
Wnt5a as a regulator of proliferation and apoptosis, hence our finding for an anti-apoptotic
role for Wnt5a in aHSC may be indicative of this being a core function for Wnt5a in tissue
fibrosis[34]. The mechanism(s) by which Wnt5a promotes aHSC survival remain to be deter-
mined, however we would argue for a β-catenin-independent mechanism. Of relevance,
Wnt5a can suppress apoptosis in other cell types via activation of NF-κB- and/or NFAT-
dependent signalling pathways[35,36]. Our laboratory and other investigators have estab-
lished a critical aHSC survival function for NF-κB, it will therefore be of interest to investi-
gate the degree to which the elevated constitutive NF-κB activity of aHSC is influenced by
Wnt5a[37]. Furthermore, in macrophages NF-κB and Wnt5a establish a self-sustaining regu-
latory circuit that supports macrophage survival[38]. The role of KC as potentiators of HSC
transdifferentiation is well established, in particular KC-derived TGF-β1 is required for initi-
ating this process. However, there is increasing awareness that communication between HSC
and hepatic immune cells is a two-way process with potential for HSC to modulate the behav-
iour of macrophages, T cells and neutrophils via secreted mediators. We were able to show
that media conditioned by Wnt5a-transfected HSC stimulates elevated expression of a subset
of KC genes including TGF-β1 and MCP1. Both of these KC-derived cytokines have stimula-
tory effects on HSC including collagen synthesis and migration[39] indicating that Wnt5a
contributes to complex two-way paracrine pro-fibrogenic signalling networks established
between aHSC and KC. Determining the degree to which HSC-derived Wnt5a is required to
maintain these intercellular signalling networks and its functional contribution to liver fibro-
sis will be important to discover but will require genetic studies in which Wnt5a expression is
selectively deleted in HSC.
In conclusion, the Wnt signalling system is a functional feature of HSC-derived myofibro-
blasts and has the potential to influence fibrogenesis via autocrine and paracrine routes. How-
ever, from our data it seems that the degree to which aHSC utilise the canonical Wnt pathway
is minimal and as such it will be important in future work to interrogate the nature and func-
tion of non-canonical Wnt signalling.
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Materials and Methods
Cell Isolation and Cell Culture
All experiments were approved by Newcastle University’s Animal Welfare and Ethical Review
Board. Animals were bred in the Newcastle University animal unit, maintained as specific
pathogen free according to the FELASA Guidelines. Work was carried out under project and
personal licences approved by the UK Home Office. HSCs were isolated from normal livers of
male Sprague-Dawley rats (following Ketamine/Xylazine anaesthesia and sacrifice by exsangui-
nation) by collagenase/pronase perfusion by density centrifugation in Optiprep (Invitrogen).
Isolated cells were pre-plated on plastic flasks for 20 mins to allow attachment and separation
of Kupffer cells. Cells harvested directly after isolation (Day 0 of culture) were considered qui-
escent. Cells harvested after 7 days of culture were considered activated. Dermal fibroblasts
were obtained from freshly harvested rat skin by collagenase A digestion. Primary cells were
maintained in humidified atmosphere of 5% CO2 in air at 37°C, cultured in Dulbecco’s modi-
fied Eagle’s medium (DMEM) supplemented with 16% foetal bovine serum (FBS), 100 U/mL
penicillin, 100 g/mL streptomycin and 2mM L-glutamine. The LX-2 cell line, a spontaneously
immortalized human hepatic stellate cell, was kindly provided by Dr. Scott L. Friedman
(Mount Sinai School of Medicine, New York, NY). Treatment reagents used were recombinant
sFRP1 and sFRP5 (5nM) (R&D systems), CT99021 (Axon MedChem), IWP2 (20μM) (Sigma),
Dvl-PDZ Domain inhibitior (Calbiochem) (5μM), ICG001 (5μM)(Tocris). Amicon Ultra-0.5
mL centrifugal filters (Millipore) were used to concentrate cell culture medium for western
blotting.
RNA extraction, cDNA synthesis and quantitative reverse transcriptase-
polymerase chain reaction (RT-PCR)
Total RNA was purified using the RNeasy kit (Qiagen) and cDNA templates prepared using a
random hexamer primer and Moloney murine leukemia virus reverse transcriptase
(MMLV-RT) (Promega). RNA from HSCs isolated from BDL or CCl4 injured mouse liver was
donated by H. Tsukamoto, as used in Mann et al [40]. RNA from human HSCs isolated from
normal margins of livers resected for removal of metastatic colorectal tumors was donated by
F.Oakley, as used in Ebrahimkhani et al [41]. PCR primers were designed using Oligo Primer
Analysis Software 4.0 (Molecular Biology Insights, Inc) (S1 Table). Reverse Transcriptase PCR
(RT-PCR) was conducted using PCR master mix (Promega) following a 35 cycle program.
Quantitative polymerase chain reaction (qPCR) was performed using a 7500 Fast system
(Applied Biosciences) following a 40 cycle program. All results were normalised to a control
housekeeping gene: GAPDH (Human) or β-Actin (Rat). Melt curve analysis was employed to
confirm presence of a single PCR product. The relative level of transcriptional difference calcu-
lated by using the following equation: [1/(2A)] ×100.
SDS-PAGE and Immunoblotting
Sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting
were done as previously described. Primary Antibodies used were CaMKII (pan) (#3362S),
Dvl2 (#3216), LEF1(C12A5)(#2230), PJNK (Thr183/Tyr185) (#9251), TCF1 (C63D9) (#2203),
TCF3 (D15G11) (#2883), TCF4 (C48H11) (#2569), TGFβ (56E4) (#3709), TJNK (#9252),
Wnt5a (C27E8) (#2530) and αTubulin (#2144) (1 in 1000) (Cell Signal), Wnt5a (#55184-
1-AP), Wnt3a (#21414-1-AP), Fzd2 (#24272-1-AP) (1 in 1000), sFRP4 (#15328-1-AP) (1 in
500) (Proteinech). GAPDH (ab9485), β-Actin(AC-15) (ab6276), β-Catenin (Total) (ab6302),
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Fzd8 (ab75235) (1 in 2000) (Abcam), p84 (5E10) (GT70220) 1 in 1000, (Genetex), β-Catenin
(Active) (8E7) (#05–665) 1 in 500 (Millipore).
Migration Assay
Cells in 6 well plates were pre-treated with Mitomycin-C (Sigma) for 30 minutes and single
scratch made in each well. Wound was measured over a 24 hour period. Results presented are
averages of ten measurements per field. Experiments were performed in triplicate.
Acridine Orange
Cells were seeded in 12-well plates at 20–30% confluency. Apoptotic cells were detected by
Acridine Orange staining (1μg/ml) (Sigma) and visualisation under a FITC filter. Five random
fields per well were counted at x20 magnification in duplicate wells.
MTT Assay
Cells seeded in 96 well plates were treated with MTT (5mg/ml, Sigma) for 4 hours. Medium
was then aspirated and cells incubated with DMSO (Sigma) for 30 minutes. Plate was read
using plate reader at 570nm absorbance.
Transfections and reporter gene assays
Cells were transfected with 1μg of plasmid DNA using Effectene transfection reagent (Qiagen)
for 48 hours before harvest. For TOPFLASH reporter assay, 0.5μg of TOPFLASH plasmid
(Millipore) was contransfected with 0.05μg of renilla luciferase plasmid serving as a transfec-
tion control. Luminescence was measured using the Dual Luciferase Reporter Kit (Promega)
and data presented as average ratios of firefly to renilla luciferase activity. Conditioned medium
was collected from transiently transfected LX-2 cells over expressing Wnt5a, Wnt10b or an
empty control construct.
Constructs
Active β-catenin construct (S37A) was provided by D.L.Johnson, as used in Orford et al[42].
Wnt3a, Wnt5a, Wnt10b, LEF1 and sFRP4 constructs were sourced from Origene.
Statistical Analysis
Data are expressed as mean ± standard error of the mean (SEM). P values were calculated
using a two-tailed paired or unpaired Student t test. For figures with statistically significant
data , , and  indicate P values of<0.05,<0.01 and<0.001, respectively.
Supporting Information
S1 Fig. (A) Western Blot analysis confirms protein expression of Fzd2 and FZd8 in qHSC and
aHSC. Fzd overexpessing LX2 cells serve as a positive control. (B) qRT-PCR analysis of sFRPs
and Dkk 3 in rat qHSC and aHSC. Results expressed as fold change normalised to
control ± SEM (n = 4).
(TIF)
S2 Fig. Western Blot confirming increased protein expression of active form of βCatenin
upon overexpression of S37 mutant βCatenin in LX2 and HEK293 cells.
(TIF)
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S3 Fig. Western Blot confirming presence of βCatenin in both nuclear and cytoplasmic
fractions of LX2 cells.Nuclear βcatenin is increased upon overexpression of S37 mutant. αTu-
bulin and p84 serve as controls of cytoplasmic and nuclear purity respectively.
(TIF)
S4 Fig. Western Blot demonstrating reduced expression of hyperphosphorylated form of
Dvl2 upon treatment of protein lysates with the dephosphorylating agent Alkaline Phos-
phatase (ALP).
(TIF)
S5 Fig. Western Blot demonstrating presence of Wnt5a protein in conditioned media col-
lected fromWnt5a overexpressing LX2 cells. Complete media (16% FBS containing DMEM)
serves as a negative control.
(TIF)
S6 Fig. (A) Western Blot demonstrating increased expression of Dvl2 in day 7 rat HSCs upon
Wnt5a or Wnt10b conditioned medium treatement (B) qRT-PCR for profibrotic markers in
rat HSCs treated with Wnt5a conditioned medium at Day3 or Day 7 of in vitro culture. Results
expressed as fold change normalised to control ± SEM (n = 3).
(TIF)
S7 Fig. (A) mRNA levels of profibrotic markers were analysed by qPCR. Results expressed as
fold change normalised to control ± SEM; n = 3 (B) Bright field microscopy images (C) Apo-
ptotic response analysed by Acridine Orange staining. Data presented as number of apoptotic
cells as percentage of total cell number (n = 3).
(TIF)
S8 Fig. Western blot demonstrating expression of proliferation markers PCNA and cMyc
in Wnt5a treated rat HSCs.
(TIF)
S9 Fig. Acridine Orange staining demonstrating increased number of apoptotic cells
(arrows) in control cells compared to Wnt5a overexpressing cells after serum starvation.
(TIF)
S1 Table. Quantitative PCR primers used for cDNA amplification.
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